Page last updated: 2024-08-25

rosiglitazone and methylnitronitrosoguanidine

rosiglitazone has been researched along with methylnitronitrosoguanidine in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, BL; Cheng, YY; Chu, WK; Hu, PJ; Leung, WK; Sung, JJ; Wong, CY; Yu, J; Zeng, ZR	1

Other Studies

1 other study(ies) available for rosiglitazone and methylnitronitrosoguanidine

Article	Year
Rosiglitazone suppresses gastric carcinogenesis by up-regulating HCaRG expression. Oncology reports, 2008, Volume: 20, Issue:5 Topics: Animals; Antineoplastic Agents; Cell Cycle Proteins; Cell Line, Tumor; Down-Regulation; Gene Expression; Humans; Immunohistochemistry; Methylnitronitrosoguanidine; Nuclear Proteins; Oligonucleotide Array Sequence Analysis; Rats; Reverse Transcriptase Polymerase Chain Reaction; Rosiglitazone; Stomach Neoplasms; Thiazolidinediones; Up-Regulation	2008

Article

Year

Rosiglitazone suppresses gastric carcinogenesis by up-regulating HCaRG expression.

Oncology reports, 2008, Volume: 20, Issue:5

Topics: Animals; Antineoplastic Agents; Cell Cycle Proteins; Cell Line, Tumor; Down-Regulation; Gene Expression; Humans; Immunohistochemistry; Methylnitronitrosoguanidine; Nuclear Proteins; Oligonucleotide Array Sequence Analysis; Rats; Reverse Transcriptase Polymerase Chain Reaction; Rosiglitazone; Stomach Neoplasms; Thiazolidinediones; Up-Regulation

2008